Bupropion interferes with the image diagnosis of Parkinson's disease
Chieh-Hsin Lin,1–3 Hsien-Yuan Lane2,4 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3Center for General Education, Che...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8c31871236b4ae1b44e6396ed651d7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b8c31871236b4ae1b44e6396ed651d7b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b8c31871236b4ae1b44e6396ed651d7b2021-12-02T07:19:59ZBupropion interferes with the image diagnosis of Parkinson's disease1178-2021https://doaj.org/article/b8c31871236b4ae1b44e6396ed651d7b2017-10-01T00:00:00Zhttps://www.dovepress.com/bupropion-interferes-with-the-image-diagnosis-of-parkinson39s-disease-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Chieh-Hsin Lin,1–3 Hsien-Yuan Lane2,4 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3Center for General Education, Cheng Shiu University, Kaohsiung, Taiwan, 4Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan Abstract: Major depressive disorder (MDD) and Parkinson’s disease (PD) share symptoms such as tremor. Bupropion, a norepinephrine–dopamine reuptake inhibitor, shows weak dopamine transporter (DAT) occupancy. We report here on a patient with MDD whose hand tremors might have been misdiagnosed as PD by single-photon emission computed tomography (SPECT) under bupropion use. A 66-year-old male patient with MDD had been receiving bupropion 150 mg per day for 6 months. His mood symptoms improved partially with bupropion treatment, however, hand tremors persisted. The neurological examination revealed bilateral hand tremors without other typical signs for PD. The SPECT using Tc-99m TRODAT-1 revealed decreased DAT binding capacity in bilateral striata. Under the impression of atypical PD, the patient was advised to take anti-Parkinson’s drug. Bupropion was discontinued for 14 days to confirm the test. The follow-up SPECT after 14 days found improvement for the uptake ratio of striata. From then onward, the anti-Parkinson’s drug was not used due to the lack of typical sign(s) for PD. The patient’s mental and physical status remained stable without worsening of hand tremors during follow-up. Tc-99m TRODAT-1 SPECT is helpful for the evaluation of DAT and the diagnosis of PD. However, the interpretation of the SPECT image might be biased by the use of certain drugs such as bupropion for its binding to DAT. Bupropion may decrease the Tc-99m TRODAT-1 binding to DAT. The effect of drugs on DAT should be carefully assessed while interpreting the Tc-99m TRODAT-1 image. Our findings suggest that all drugs that may alter DAT occupancy should be listed as the reference for Tc-99m TRODAT-1 image reading. Keywords: bupropion, dopamine transporter, single-photon emission computed tomography, Parkinson’s disease, Tc-99m TRODAT-1Lin CHLane HYDove Medical Pressarticlebupropiondopamine transportersingle-photon emission computed tomographyParkinson diseaseTc-99m TRODAT-1Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2637-2639 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
bupropion dopamine transporter single-photon emission computed tomography Parkinson disease Tc-99m TRODAT-1 Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
bupropion dopamine transporter single-photon emission computed tomography Parkinson disease Tc-99m TRODAT-1 Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Lin CH Lane HY Bupropion interferes with the image diagnosis of Parkinson's disease |
description |
Chieh-Hsin Lin,1–3 Hsien-Yuan Lane2,4 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 3Center for General Education, Cheng Shiu University, Kaohsiung, Taiwan, 4Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan Abstract: Major depressive disorder (MDD) and Parkinson’s disease (PD) share symptoms such as tremor. Bupropion, a norepinephrine–dopamine reuptake inhibitor, shows weak dopamine transporter (DAT) occupancy. We report here on a patient with MDD whose hand tremors might have been misdiagnosed as PD by single-photon emission computed tomography (SPECT) under bupropion use. A 66-year-old male patient with MDD had been receiving bupropion 150 mg per day for 6 months. His mood symptoms improved partially with bupropion treatment, however, hand tremors persisted. The neurological examination revealed bilateral hand tremors without other typical signs for PD. The SPECT using Tc-99m TRODAT-1 revealed decreased DAT binding capacity in bilateral striata. Under the impression of atypical PD, the patient was advised to take anti-Parkinson’s drug. Bupropion was discontinued for 14 days to confirm the test. The follow-up SPECT after 14 days found improvement for the uptake ratio of striata. From then onward, the anti-Parkinson’s drug was not used due to the lack of typical sign(s) for PD. The patient’s mental and physical status remained stable without worsening of hand tremors during follow-up. Tc-99m TRODAT-1 SPECT is helpful for the evaluation of DAT and the diagnosis of PD. However, the interpretation of the SPECT image might be biased by the use of certain drugs such as bupropion for its binding to DAT. Bupropion may decrease the Tc-99m TRODAT-1 binding to DAT. The effect of drugs on DAT should be carefully assessed while interpreting the Tc-99m TRODAT-1 image. Our findings suggest that all drugs that may alter DAT occupancy should be listed as the reference for Tc-99m TRODAT-1 image reading. Keywords: bupropion, dopamine transporter, single-photon emission computed tomography, Parkinson’s disease, Tc-99m TRODAT-1 |
format |
article |
author |
Lin CH Lane HY |
author_facet |
Lin CH Lane HY |
author_sort |
Lin CH |
title |
Bupropion interferes with the image diagnosis of Parkinson's disease |
title_short |
Bupropion interferes with the image diagnosis of Parkinson's disease |
title_full |
Bupropion interferes with the image diagnosis of Parkinson's disease |
title_fullStr |
Bupropion interferes with the image diagnosis of Parkinson's disease |
title_full_unstemmed |
Bupropion interferes with the image diagnosis of Parkinson's disease |
title_sort |
bupropion interferes with the image diagnosis of parkinson's disease |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/b8c31871236b4ae1b44e6396ed651d7b |
work_keys_str_mv |
AT linch bupropioninterfereswiththeimagediagnosisofparkinson39sdisease AT lanehy bupropioninterfereswiththeimagediagnosisofparkinson39sdisease |
_version_ |
1718399475304628224 |